Somnoware Healthcare Systems has raised $9 million in Series A round of funding led by TransLink Capital, with participation from World Innovation Lab (WiL) and existing investors. The company will use the money to further fulfill its mission to connect, organize and analyze clinical sleep information that enables its customers to better manage sleep apnea, lower costs and improve patient outcomes.

“With this investment – and the rapid adoption across the sleep community with systems like Carolinas HealthCare and Advocate Health Care – we’re well on the way to achieving our vision of advancing health by providing insights and solutions to improve sleep,” Subath Kamalasan, CEO of Somnoware, said in a statement. “Now we can extend the platform and add even more capabilities that will further our leadership position.”

Somnoware provides a cloud-based platform that can work across all devices, manufacturers and EMRs, bridging different data silos and making the data readily accessible and useful for patients, clinicians, payors, device manufacturers and researchers.

With a comprehensive view of sleep data and a single point of access to patient information in one unified platform, providers can use Somnoware’s analytics to achieve the detailed outcome measurement and reporting required for participation in accountable care.

According to a Harvard-McKinsey study, poorly managed sleep apnea costs the US economy over $150 billion per year. Researchers report that over 75% of the 45 million Americans that suffer from sleep disorders are not diagnosed.